The Importance of Knowing the Local Epidemiology When a Patient With Cirrhosis Acquires a Bacterial Infection
Sebastián Marciano, Marcelo Valverde, Melisa Dirchwolf, María Nelly Gutierrez‐Acevedo, Adrián Gadano – 22 September 2020
Hepatitis B Virus and Delta Infection: Special Considerations in the Indigenous and Isolated Riverside Populations in the Amazon Region
César Cabezas, Wornei Braga – 22 September 2020
Consequences of Extended Spectrum Beta‐Lactamase–Producing Enterobacteriaceae and Methicillin‐Resistant Staphylococcus aureus Carriage in Awaiting Liver Transplant Patients
Bianca Magro, Alessandra Mazzola, Mona Munteanu, Claire Goumard, Valerie Martinez, Denis Bernard, Olivier Scatton, Salvatore Battaglia, Ciro Celsa, Calogero Cammà, Filomena Conti – 21 September 2020 – Infections in patients with cirrhosis are associated with liver‐related complications (LRCs), especially in patients awaiting liver transplantation (LT). The aim of this study was to evaluate the impact of methicillin‐resistant Staphylococcus aureus (MRSA) and extended spectrum beta‐lactamase colonization on infections and LRCs for patients on the wait list and on infections after LT.
DNA Methylation of Cannabinoid Receptor Interacting Protein 1 Promotes Pathogenesis of Intrahepatic Cholangiocarcinoma Through Suppressing Parkin‐Dependent Pyruvate Kinase M2 Ubiquitination
Diyu Chen, Hao Wu, Xiaode Feng, Yunhao Chen, Zhen Lv, Vishnu Goutham Kota, Junru Chen, Wenxuan Wu, Yuejie Lu, Hua Liu, Yanpeng Zhang, Shusen Zheng, Jian Wu – 21 September 2020
Successful Auxiliary Liver Transplant Followed by Hematopoietic Stem Cell Transplantation in X‐Linked Lymphoproliferative Disease Type 1
Marie‐Eve Chartier, Maesha Deheragoda, Michael Gattens, Anil Dhawan, Nigel Heaton, Claire Booth, Nedim Hadžić – 19 September 2020
LiverLearning®: 2020 Webinar: Current and Future Disease Burden of HBV: Global and Regional Perspectives
In this on-demand webinar, representative speakers from Africa including North and Sub-Saharan Africa (Mark W. Sonderup, South Africa), East Asia (Jidong Jia, China), West and South Asia (Shiv K. Sarin, India), Europe including Western and Eastern Europe (George V. Papatheodoridis, Greece), North America (Carla Coffin, Canada) and South/Central America (Adrian Gadano) will each talk on HBV disease burden and primary challenges in their respective regions. They will present the current status and predictions for the next decade.
Sequential Use of Normothermic Regional and Ex Situ Machine Perfusion in Donation After Circulatory Death Liver Transplant
Davide Ghinolfi, Daniele Dondossola, Erion Rreka, Caterina Lonati, Daniele Pezzati, Andrea Cacciatoinsilla, Alessia Kersik, Chiara Lazzeri, Alberto Zanella, Adriano Peris, Marco Maggioni, Giandomenico Biancofiore, Paolo Reggiani, Riccardo Morganti, Paolo De Simone, Giorgio Rossi – 18 September 2020 – In Italy, 20 minutes of a continuous flat line on an electrocardiogram are required for declaration of death.
Reproductive Health and Liver Disease: Practice Guidance by the American Association for the Study of Liver Diseases
Monika Sarkar, Carla W. Brady, Jaquelyn Fleckenstein, Kimberly A. Forde, Vandana Khungar, Jean P. Molleston, Yalda Afshar, Norah A. Terrault – 18 September 2020
Reproductive Health and Liver Disease: Practice Guidance by the American Association for the Study of Liver Diseases
Monika Sarkar, Carla W. Brady, Jaquelyn Fleckenstein, Kimberly A. Forde, Vandana Khungar, Jean P. Molleston, Yalda Afshar, Norah A. Terrault – 18 September 2020
Patient Frailty Is Independently Associated With the Risk of Hospitalization for Acute‐on‐Chronic Liver Failure
Shivani Shah, David S. Goldberg, David E. Kaplan, Vinay Sundaram, Tamar H. Taddei, Nadim Mahmud – 18 September 2020 – There is significant interest in identifying risk factors associated with acute‐on‐chronic liver failure (ACLF). In transplant candidates, frailty predicts wait‐list mortality and posttransplant outcomes. However, the impact of frailty on ACLF development and mortality is unknown. This was a retrospective study of US veterans with cirrhosis identified between 2008 and 2016. First hospitalizations were characterized as ACLF or non‐ACLF admissions.